Filing Details
- Accession Number:
- 0000950170-24-109133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-24 17:26:24
- Reporting Period:
- 2024-09-23
- Accepted Time:
- 2024-09-24 17:26:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1783328 | Tscan Therapeutics Inc. | TCRX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1647647 | Barbara Klencke | C/O Tscan Therapeutics, Inc. 830 Winter Street Waltham MA 02451 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Voting Common Stock | Acquisiton | 2024-09-23 | 5,000 | $5.29 | 45,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Voting Common Stock | 25,000 | Indirect | By Trust |
Footnotes
- Shares held by the Klencke Huestis Trust, for which the Reporting Person serves as co-trustee along with her spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.